Travere Therapeutics: Bank of America reports 7.1%
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Travere Therapeutics, Inc. (TVTX) is the subject of an amended beneficial-ownership report by Bank of America Corporation, which reported beneficial ownership of 6,810,705 shares, or 7.1%, as of September 30, 2026. The ownership percentage was calculated using 95,673,465 shares outstanding as of that date, as reported by the company.
Bank of America Corporation filed on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, Merrill Lynch Pierce Fenner & Smith, Inc., and U.S. Trust Co of Delaware. It reported shared voting power over 6,379,726 shares and shared dispositive power over 6,697,284 shares.
Key Figures
Key Terms
beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.